These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21486210)

  • 1. Exploring QSAR, pharmacophore mapping and docking studies and virtual library generation for cycloguanil derivatives as PfDHFR-TS inhibitors.
    Ojha PK; Roy K
    Med Chem; 2011 May; 7(3):173-99. PubMed ID: 21486210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship and comparative docking studies for cycloguanil analogs as PfDHFR-TS inhibitors.
    Sivaprakasam P; Tosso PN; Doerksen RJ
    J Chem Inf Model; 2009 Jul; 49(7):1787-96. PubMed ID: 19588935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of molecular docking and PSO-SVR intelligent approaches in antimalarial activity prediction of enantiomeric cycloguanil analogues.
    Inthajak K; Toochinda P; Lawtrakul L
    SAR QSAR Environ Res; 2018 Dec; 29(12):957-974. PubMed ID: 30381963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new non-pyrimidine scaffolds as
    Hoarau M; Vanichtanankul J; Srimongkolpithak N; Vitsupakorn D; Yuthavong Y; Kamchonwongpaisan S
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):198-206. PubMed ID: 33530764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shape- and chemical feature-based 3D-pharmacophore model generation and virtual screening: identification of potential leads for P. falciparum DHFR enzyme inhibition.
    Adane L; Patel DS; Bharatam PV
    Chem Biol Drug Des; 2010 Jan; 75(1):115-26. PubMed ID: 19895504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring structural requirements for a class of nucleoside inhibitors (PfdUTPase) as antimalarials: first report on QSAR, pharmacophore mapping and multiple docking studies.
    Ojha PK; Roy K
    Comb Chem High Throughput Screen; 2013 Nov; 16(9):739-57. PubMed ID: 23701009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between cycloguanil derivatives and wild type and resistance-associated mutant Plasmodium falciparum dihydrofolate reductases.
    Maitarad P; Kamchonwongpaisan S; Vanichtanankul J; Vilaivan T; Yuthavong Y; Hannongbua S
    J Comput Aided Mol Des; 2009 Apr; 23(4):241-52. PubMed ID: 19156529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.
    Japrung D; Leartsakulpanich U; Chusacultanachai S; Yuthavong Y
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4356-60. PubMed ID: 17875995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative structure-activity relationships for cycloguanil analogs as PfDHFR inhibitors using mathematical molecular descriptors.
    Basak SC; Mills D
    SAR QSAR Environ Res; 2010 Apr; 21(3-4):215-29. PubMed ID: 20544548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme.
    Adane L; Bharatam PV
    J Mol Graph Model; 2009 Nov; 28(4):357-67. PubMed ID: 19796975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a lead inhibitor for the A16V+S108T mutant of dihydrofolate reductase from the cycloguanil-resistant strain (T9/94) of Plasmodium falciparum.
    Yuthavong Y; Vilaivan T; Chareonsethakul N; Kamchonwongpaisan S; Sirawaraporn W; Quarrell R; Lowe G
    J Med Chem; 2000 Jul; 43(14):2738-44. PubMed ID: 10893311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the role of the junctional region of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase.
    Chaianantakul N; Sirawaraporn R; Sirawaraporn W
    Malar J; 2013 Mar; 12():91. PubMed ID: 23497065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach.
    Parenti MD; Pacchioni S; Ferrari AM; Rastelli G
    J Med Chem; 2004 Aug; 47(17):4258-67. PubMed ID: 15293997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
    Basco LK; Ringwald P
    Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key interactions of pyrimethamine derivatives specific to wild-type and mutant
    Seetin S; Saparpakorn P; Vanichtanankul J; Vitsupakorn D; Yuthavong Y; Kamchonwongpaisan S; Hannongbua S
    J Biomol Struct Dyn; 2023; 41(12):5728-5743. PubMed ID: 35815526
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined spatial limitation around residues 16 and 108 of Plasmodium falciparum dihydrofolate reductase explains resistance to cycloguanil.
    Vanichtanankul J; Taweechai S; Uttamapinant C; Chitnumsub P; Vilaivan T; Yuthavong Y; Kamchonwongpaisan S
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3928-35. PubMed ID: 22526319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of solution-phase combinatorial library of 4,6-diamino-1,2-dihydro-1,3,5-triazine and identification of new leads against A16V+S108T mutant dihydrofolate reductase of Plasmodium falciparum.
    Vilaivan T; Saesaengseerung N; Jarprung D; Kamchonwongpaisan S; Sirawaraporn W; Yuthavong Y
    Bioorg Med Chem; 2003 Jan; 11(2):217-24. PubMed ID: 12470716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial effect of cell penetrating peptides derived from the junctional region of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase.
    Chaianantakul N; Sungkapong T; Supatip J; Kingsang P; Kamlaithong S; Suwanakitti N
    Peptides; 2020 Sep; 131():170372. PubMed ID: 32673701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico ADMET study, docking, synthesis and antimalarial evaluation of thiazole-1,3,5-triazine derivatives as Pf-DHFR inhibitor.
    Sahu S; Ghosh SK; Gahtori P; Pratap Singh U; Bhattacharyya DR; Bhat HR
    Pharmacol Rep; 2019 Oct; 71(5):762-767. PubMed ID: 31351317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.